Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to Multi-Column Chromatography for Continuous Processing
Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gantier, Ph.D.
Navigating Technology Transfer
Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies
James Barry, Director of Marketing, Americas, Pall Biotech
Bringing the Freezing of Biopharmaceuticals in From the Cold
View All Featured ArticlesHeadline News
Lunsumio plus lenalidomide improves progression free survival in Phase III follicular lymphoma trial
Robigo raises Series A led by Leaps by Bayer to advance engineered crop protection biologicals
Körber certifies ZETA’s INOSIM Foresight for PAS X MES data integration
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Advances in the Purification of Antisense Oligonucleotides
Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen and John Cyganowski, Director of Customer Application, Downstream, Merck
27th October 2021
Best Practices of Downstream Protein Purification and Product Concentration
Presented by Krishnamurthy Venkatesan, Downstream MSAT Lead, Director at Biocon Biologics, Sofie Östemar, Product Manager for Connected & Continuous Downstream Processing and Henrik Ihre, Ph.D. Director Strategic Technologies at Cytiva and Nigel Jackson Principal Engineer, Bioprocessing R&D at Pall Corporation
12th October 2022
FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing
Presented by Lily Koo, Consumer Safety Officer at Food and Drug Administration and Keen Chung, Principal Scientist (Upstream Process) at Pall Biotech, Analytics Lead
16th October 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Best Practices for Achieving Virus Safety
Column Packing Protocol for Amsphere A3
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















